Oric Pharmaceuticals, Inc. (ORIC) Insider Trading

Name: Oric Pharmaceuticals, Inc. (ORIC) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 2, 2026): Heyman Richard A. (Director): Exercise/Conversion of 3,500 shares, $5.6K.

Get alerted when insiders trade ORIC

Email address

Loading company data...

Loading company details...